Molecular Devices’ foundational planar patch-clamp patent upheld by European Patent Office
European Patent Office Appeal Board Rules in Favor of Alnylam’s Kreutzer-Limmer Patent
CAMBRIDGE, Mass.—-Alnylam Pharmaceuticals, Inc. , a leading RNAi therapeutics company, announced today that the Board of Appeals of the European Patent Office has ruled that claims of the Kreutzer-Limmer ’945 patent meet needed requirements under European patent law.
Read more on Business Wire via Yahoo! Finance
U.S. Patent and Trademark Office Grants athenahealth a Patent for its Automated Implementation System for Medical …
WATERTOWN, Mass.—-athenahealth, Inc. , a leading provider of Internet-based business services to physician practices, today announced that on May 18, 2010, the U.S. Patent and Trademark Office issued athenahealth a patent entitled, ‘Automated Configuration of Medical Practice Management Systems’ related to its automated Self-Service Implementation capability.
Read more on Business Wire via Yahoo! Finance
Progen says European patent granted
Cancer drug developer Progen Pharmaceuticals Ltd says a European patent has been granted for a new technology therapeutic compound that it has licensed.
Read more on Brisbane Times
Cisco Told to Pay Commil $3.7 Million Over Patent (Update1)
Cisco Systems Inc., the biggest maker of networking equipment, was told to pay $3.7 million in patent royalties to Commil USA LLC over technology that ensures laptops and mobile phones stay connected to wireless networks.
Read more on BusinessWeek
Molecular Devices’ foundational planar patch-clamp patent upheld by European Patent Office
Molecular Devices today announced that European Patent Office (EPO) has upheld Molecular Devices foundational planar patch-clamp patent (EP No 1 040 349 B1). The board will issue a written decision to this effect in the near future. The ruling will be the final determination of the EPO and cannot be appealed.
Read more on News-Medical-Net
Related Topics
Leave a Reply
